4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0002044770-26-000004
Director acquired 2,954 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Goodrich Katherine · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-12 | Exercise or conversion : show line 1 in the form | +2,954 | 5,187 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-12 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −2,954 | 0 | D |
Loading xslF345X06/wk-form4_1781640353.xml…